Clinical Trials Directory

Trials / Unknown

UnknownNCT03605472

Comparison of Cervical Ultrasound and Echoscintigraphy for Preoperative Localization Diagnosis in Primary Hyperparathyroidism

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
CHU de Reims · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The biological diagnosis of the primary hyperparathyroidism is now facilitated by the reliability of the balance of phosphate and calcium and the dosage of parathyroid hormone (PTH). This diagnosis of preoperative localization is important as surgery are now targeted to the responsible lesion. The "gold standard" for this localization is the cervical ultrasound exploring the usual sites of adenomas and a MIBI scintigraphy (the parathyroid adenoma significantly concentrating this cell marker). However, the diagnosis of preoperative localization remains a subject of discussion as to the most appropriate tests. Indeed, the morphological diagnosis is performed at the ultrasound stage in more than half the cases. It is the new performance of this morphological examination that makes it possible to obtain these results.

Conditions

Interventions

TypeNameDescription
OTHERcervical ultrasoundcervical ultrasound will be realized by a endocinologist trained in the cervical ultrasound

Timeline

Start date
2017-10-05
Primary completion
2019-10-05
Completion
2020-03-05
First posted
2018-07-30
Last updated
2018-07-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03605472. Inclusion in this directory is not an endorsement.